FibroBiologics Inc
FBLG
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.37M
Close$
$1.11
28.2% downside
Current Fair Value
28.2% downsideOvervalued by 28.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.37 Million |
|---|---|
| Enterprise Value | $1.20 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.35 |
| Beta | 1.22 |
| Outstanding Shares | 3,772,930 |
Return
| Return on Equity | -391.26% |
|---|---|
| Return on Assets | -228.77% |
| Return on Invested Capital | -313.49% |
Valuation & Multiples
| P/E Ratio | -0.27 |
|---|---|
| PEG | 2.31 |
| Price to Sales | - |
| Price to Book Ratio | 1.55 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.07 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.12 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 31, 2026
EPS Estimate
$-0.93
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
$-0.63
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 7.55%▲ 1.70% |
|---|---|
| Total Invested | $269,614▼ 7.45% |
| Investors Holding | 16▼ 1.00% |
ESG Score
No data